E.-U. Würthwein et al.
FULL PAPER
3032 (vw), 2997 (vw), 2988 (vw), 1692 (vw), 1676 (vw), 1624 (vs),
1603 (vs), 1593 (vs), 1572 (s), 1543 (w), 1522 (vw), 1489 (m), 1474
(m), 1454 (vs), 1425 (w), 1404 (m), 1383 (s), 1371 (vs), 1354 (s),
1333 (vw), 1315 (w), 1300 (w), 1275 (vw), 1261 (vw), 1225 (s), 1209
(w), 1015 (vs), 976 (m), 955 (m), 934 (w), 922 (w), 858 (w), 826
(vs), 818 (vs), 800 (vs), 772 (vs), 764 (vs), 716 (vs), 689 (s), 665 (m),
1
633 (w), 608 (s) cm–1. H NMR (CD2Cl2, 400.13 MHz): δ = 3.75
2
(d, J = 2.8 Hz, 1 H, CH2,olef.), 4.58–4.59 (m, 1 H, CH2,olef.), 4.70
3
(m), 1175 (m), 1157 (w), 1148 (w), 1126 (w), 1115 (s), 1074 (w), (s, 2 H, CH2), 7.16 (t, J = 7.6 Hz, 1 H, CHarom.), 7.23–7.35 (m, 6
1057 (w), 1028 (w), 974 (s), 941 (vw), 922 (s), 903 (w), 853 (m), 800
(vw), 779 (s), 758 (vs), 750 (vs), 735 (vs), 700 (vs), 694 (vs), 667
(vw), 644 (vw), 625 (m), 610 (vw) cm–1. 1H NMR (CD2Cl2,
300.13 MHz): δ = 3.66 (d, 3J = 3.0 Hz, 1 H, CH2,olef.), 3.90 (s, 2 H,
H, CHarom.), 7.41 (s, 1 H, CH=N), 7.57 (d, 3J = 8.0 Hz, 1 H,
CHarom.) ppm. 13C NMR (CD2Cl2, 100.61 MHz): δ = 46.2 (CH2),
80.3 (CH2,olef.), 123.2 (Cquat.), 126.8, 127.3, 128.6, 128.9, 129.1,
129.5, 130.6 (CHarom.), 133.9, 134.6, 140.2, 142.5, 142.9 (Cipso),
CH2), 4.48–4.50 (m, 1 H, CH2,olef.), 6.83–6.91 (m, 3 H, CHarom.), 148.3 (CH=N) ppm. HRMS (ESI): calcd. for C16H13ClN2H
3
6.96 (s, 1 H, CH=N), 6.97–7.13 (m, 4 H, CHarom.), 7.40 (dd, J = 269.0840; found 269.0840.
4
3
4
8.1, J = 1.5 Hz, 1 H, CHarom.), 7.62 (dd, J = 7.8, J = 1.2 Hz, 1
H, CHarom.) ppm. 13C NMR (C6D6, 75.47 MHz): δ = 53.4 (CH2),
79.8 (CH2,olef.), 123.0 (CHarom.), 123.5 (Cquat.), 126.4, 126.5, 127.6,
127.8, 129.0, 130.3 (CHarom.), 135.7, 140.2, 143.1 (Cipso), 147.9
(CH=N) ppm. HRMS (ESI): calcd. for C16H14N2H 235.1230;
found 235.1230. C16H14N2 (234.30): calcd. C 82.02, H 6.02, N
11.96; found C 81.74, H 5.85, N 11.57.
3-(4-Methoxybenzyl)-4-methylene-3,4-dihydroquinazoline
(6d):
Compound 3a (0.76 g, 5.20 mmol) was dissolved in dry CH2Cl2
(50 mL). Then, 4-methoxybenzylamine (0.69 mL, 5.30 mmol) was
added. Recrystallization from CH2Cl2 gave 6d (0.42 g, 1.60 mmol,
31%) as yellow crystals, m.p. 141–142 °C. IR (neat): ν = 3038 (vw),
˜
3007 (w), 2955 (w), 2936 (vw), 2835 (vw), 2363 (w), 2342 (vw), 1630
(s), 1611 (m), 1595 (s), 1587 (m), 1562 (m), 1547 (m), 1533 (w),
X-ray Crystal Structure Analysis of 6a:[11] Formula C16H16N2, M = 1508 (s), 1477 (m), 1460 (s), 1441 (w), 1425 (w), 1404 (m), 1373 (s),
234.29, yellow crystal 0.30ϫ 0.25 ϫ 0.25 mm, a = 9.680(1), b =
1364 (m), 1315 (m), 1292 (m), 1277 (w), 1238 (s), 1229 (s), 1206
(m), 1175 (s), 1152 (m), 1115 (w), 1101 (w), 1080 (w), 1055 (w),
1026 (m), 1011 (m), 980 (m), 962 (m), 928 (m), 910 (w), 887 (w),
878 (w), 856 (w), 837 (w), 816 (m), 779 (vs), 762 (vs), 746 (m), 712
6.179(1), c = 20.601(3) Å, β = 92.94(1)°, V = 1230.6(3) Å3, ρcalc
=
1.265 gcm–3, μ = 0.583 mm–1, empirical absorption correction
(0.845 Յ T Յ 0.868), Z = 4, monoclinic, space group P21/c (No.
14), λ = 1.54178 Å, T = 223(2) K, ω and φ scans, 8219 reflections
collected (Ϯh, Ϯk, Ϯl), [(sinθ) / λ] = 0.60 Å–1, 2110 independent
(Rint = 0.039) and 1902 observed reflections [IՆ 2σ(I)], 163 refined
parameters, R = 0.046, wR2 = 0.126, max. (min.) residual electron
density 0.11 (–0.14) eÅ–3, hydrogen atoms calculated and refined
as riding atoms.
1
(w), 696 (w), 687 (w), 669 (w), 650 (w), 627 (w), 608 (w) cm–1. H
2
NMR (CD2Cl2, 300.13 MHz): δ = 3.78 (s, 3 H, OCH3), 3.85 (d, J
= 2.7 Hz, 1 H, CH2,olef.), 4.60 (dd, 2J = 2.7, 5J = 0.9 Hz, 1 H,
CH2,olef.), 4.65 (s, 2 H, CH2), 6.87–6.92 (m, 2 H, CHarom.), 7.13–
7.27 (m, 4 H, CHarom.), 7.30–7.34 (m, 1 H, CHarom.), 7.34 (s, 1 H,
CH=N), 7.58 (d, 3J = 9.0 Hz, 1 H, CHarom.) ppm. 13C NMR
(CD2Cl2, 75.48 MHz): δ = 53.6 (CH2), 55.8 (OCH3), 80.0 (CH2,o-
lef.), 114.7, 123.2 (CHarom.), 123.5 (Cquat.), 126.6, 127.2 (CHarom.),
127.6 (Cipso), 128.5, (CHarom.), 140.3, 142.6 (Cipso), 148.4 (CH=N),
159.8 (Cipso) ppm. HRMS (ESI): calcd. for C17H16N2OH 265.1335;
found 265.1319.
3-(4-Methylbenzyl)-4-methylene-3,4-dihydroquinazoline (6b): Com-
pound 3a (0.28 g, 1.90 mmol) was dissolved in dry CH2Cl2
(50 mL). Then, 4-methylbenzylamine (0.25 mL, 1.94 mmol) was
added. Recrystallization from toluene gave 6b (0.36 g, 1.46 mmol,
77%) as a pale orange solid, m.p. 91–92 °C. IR (neat): ν = 3049
˜
(w), 3030 (w), 3013 (w), 3007 (w), 2924 (w), 2334 (w), 1674 (m), X-ray Crystal Structure Analysis of 6d:[11] Formula C17H16N2O, M
1630 (m), 1607 (m), 1595 (s), 1566 (m), 1516 (m), 1485 (m), 1474 = 264.32, yellow crystal 0.35ϫ 0.20ϫ 0.05 mm, a = 9.2898(2), b =
(m), 1462 (m), 1454 (m), 1396 (m), 1368 (s), 1312 (m), 1300 (m), 14.0573(4), c = 10.5040(3) Å, β = 94.694(1)°, V = 1367.11(6) Å3,
1273 (m), 1252 (m), 1223 (m), 1204 (m), 1182 (m), 1173 (m), 1155 ρcalc = 1.284 gcm–3, μ = 0.081 mm–1, empirical absorption correc-
(m), 1119 (m), 1103 (m), 1080 (m), 1038 (w), 1020 (m), 989 (w),
976 (w), 962 (m), 949 (m), 932 (m), 885 (w), 870 (w), 856 (m), 839 (No. 14), λ = 0.71073 Å, T = 223(2) K, ω and φ scans, 7577 reflec-
(w), 818 (m), 775 (s), 762 (s), 746 (vs), 698 (m), 669 (m), 662 (m),
tions collected (Ϯh, Ϯk, Ϯl), [(sinθ) / λ] = 0.66 Å–1, 3174 indepen-
tion (0.972 Յ T Յ 0.996), Z = 4, monoclinic, space group P21/c
652 (w), 640 (m), 627 (m), 611 (m), 592 (m), 583 (m), 571 (m), 563 dent (Rint = 0.035) and 2501 observed reflections [IՆ 2σ(I)], 182
1
(m), 552 (w), 546 (w), 538 (m), 528 (m), 511 (m) cm–1. H NMR
refined parameters, R = 0.061, wR2 = 0.143, max. (min.) residual
electron density 0.16 (–0.16) eÅ–3, hydrogen atoms calculated and
refined as riding atoms.
(CD2Cl2, 300.13 MHz): δ = 2.34 (s, 3 H, CH3), 3.82 (d, 2J = 2.6 Hz,
2
5
1 H, CH2,olef.), 4.58 (dd, J = 2.6, J = 0.9 Hz, 1 H, CH2,olef.), 4.68
(s, 2 H, CH2), 7.13–7.18 (m, 5 H, CHarom.), 7.23–7.27 (m, 1 H,
CHarom.), 7.30–7.36 (m, 1 H, CHarom.), 7.42 (s, 1 H, CH=N), 7.57
(dd, 3J = 8.0, 4J = 1.4 Hz, 1 H, CHarom.) ppm. 13C NMR (CD2Cl2,
75.47 MHz): δ = 21.3 (CH3), 54.1 (CH2), 80.0 (CH2,olef.), 123.2
(CHarom.), 123.5 (Cquat.), 126.7, 127.1, 127.2, 130.0, 130.5 (CHarom.),
132.8, 138.2, 140.4, 142.7 (Cipso), 148.5 (CH=N) ppm. HRMS
(ESI): calcd. for C17H16N2H 249.1386; found 249.1372.
3-(2,4-Dimethoxybenzyl)-4-methylene-3,4-dihydroquinazoline (6e):
Compound 3a (1.02 g, 5.00 mmol) was dissolved in dry CH2Cl2
(50 mL). Then, 3,4-dimethoxybenzylamine (0.77 mL, 5.10 mmol)
was added. Recrystallization from toluene/ethyl acetate gave 6e
(0.35 g, 1.20 mmol, 24%), m.p. 95 °C. IR (neat): ν = 2994 (w), 2947
˜
(w), 2845 (w), 2835 (w), 1626 (m), 1603 (m), 1589 (m), 1572 (m),
1506 (m), 1485 (m), 1462 (m), 1435 (m), 1412 (m), 1385 (m), 1377
(m), 1306 (m), 1283 (m), 1269 (m), 1231 (m), 1209 (vs), 1194 (m),
3-(4-Chlorobenzyl)-4-methylene-3,4-dihydroquinazoline (6c): Isocy-
anide 3a (0.74 g, 5.00 mmol) was dissolved in dry CH2Cl2 (50 mL), 1184 (m), 1161 (m), 1121 (m), 1103 (vs), 1078 (m), 1069 (w), 1038
and the mixture was stirred at room temp. Then, 4-chlorobenzyla-
mine (0.63 mL, 5.17 mmol) was added. Recrystallization from
CH2Cl2 gave 6c (0.42 g, 1.55 mmol, 31%) as a colourless solid, m.p.
(vs) cm–1. 1H NMR (400.13 MHz, CD2Cl2): δ = 3.78 (s, 3 H,
OCH3), 3.85 (s, 3 H, OCH3), 3.91 (d, 2J = 2.6 Hz, 1 H, CH=CH2),
4.56 (m, 1 H, CH=CH2), 4.61 (s, 2 H, CH2), 6.44–6.46 (m, 1 H,
3
118–119 °C. IR (neat): ν = 3258 (w), 3219 (w), 2999 (w), 2984 (w), CHarom.), 6.50 (d, J = 2.4 Hz, 1 H, CHarom.), 7.08–7.15 (m, 2 H,
˜
2812 (w), 2803 (w), 1614 (vs), 1597 (vs), 1570 (vs), 1522 (w), 1491
(vs), 1481 (vs), 1458 (s), 1452 (s), 1437 (w), 1418 (w), 1402 (m),
1387 (vs), 1356 (vs), 1298 (w), 1281 (w), 1234 (m), 1227 (m), 1207
(s), 1190 (w), 1159 (vs), 1130 (s), 1090 (vs), 1074 (s), 1053 (m), 1036
CHarom.), 7.29–7.22 (m, 1 H, CHarom.), 7.28–7.32 (m, 1 H, CHarom.),
7.39 (s, 1 H, CH=N), 7.56–7.58 (m, 1 H, CHarom.) ppm. 13C NMR
(100.62 MHz, CD2Cl2): δ = 49.3 (CH2), 55.9, 56.0 (OCH3), 79.1
(CH2,olef.), 99.0, 104.7 (CHarom.), 115.4 (Cquat.,ipso), 123.2 (CHarom.),
4950
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 4944–4952